Gracell Biotechnologies (GRCL) Financials

$10.25

$0.00 (0.00%)

As on 22-Feb-2024 09:30EDT

Market cap

$990 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

4.4

Div. Yield

0 %

Annual
Quarterly

Income Statement (CN¥ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	--	--	0.37	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	0.37	--	--	--
Operating Expenses	578.83	624.66	463.94	214.40	146.58	62.50
Operating Profit (EBIT)	-578.83	-624.66	-463.57	-214.40	-146.58	-62.50
Other Income	--	--	--	--	--	--
Profit before Tax	-496.92	-607.49	-451.75	-211.90	-138.66	-60.79
Provision for Tax	0.06	0.02	14.13	-14.74	-6.49	1.71
Profit after Tax (Net Income)	-496.98	-607.51	-465.88	-197.16	-132.18	-60.79
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-333.57	-607.51	-453.74	-274.63	-200.86	-72.99

Liabilities (CN¥ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	1,621.09	1,375.77	1,827.37	819.66	255.36	2.38
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	39.39	59.87	77.64	51.93	138.70	138.70
Current Liabilities	229.48	220.64	155.12	93.36	18.17	7.44
Total Liabilities	2,119.43	1,656.28	2,060.14	964.95	412.22	148.52

Assets (CN¥ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	115.70	160.52	175.06	149.48	71.86	20.56
Current Assets	1,774.25	1,495.76	1,885.08	815.47	340.35	127.96
Total Assets	2,119.43	1,656.28	2,060.14	964.95	412.22	148.52
Total Debt*	115.82	182.98	155.18	102.89	138.70	138.70
Net Current Assets	1,544.78	1,275.11	1,729.96	722.11	322.19	120.52

Cashflow (CN¥ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-3,307.10	-304.55	-198.15	-135.39	-61.86
Cash Flow from Investing Activities	--	-331.17	-41.62	-93.94	41.37	-113.36
Cash from Financing Activities	--	228.34	1,456.19	756.47	394.80	138.70
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS (CN¥)	-27.92	-8.97	-7.08	-3.24	-33.36	-1.64
Cash EPS (CN¥)	--	-7.83	-6.17	-2.88	-32.07	-1.56
Adjusted Book Value (CN¥)	--	20.32	27.78	13.46	64.45	0.06
Dividend per Share (CN¥)	--	--	--	--	--	--
Cash Flow per Share (CN¥)	--	-48.86	-4.63	-3.25	-34.17	-1.67
Free Cash Flow per Share (CN¥)	--	-53.75	-5.49	-4.56	-48.42	-1.98

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-34.31	-32.07	-29.95	-49.40	--
ROE (%)	-35.10	-37.93	-35.20	-36.68	-102.57	--
ROA (%)	-23.64	-32.69	-30.80	-28.63	-47.14	--
EBIT Margin (%)	--	--	-126,659.29	--	--	--
Net Margin (%)	--	--	-127,289.62	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	--	-1.00	--	--	--	--
EBIT Growth (%)	5.96	-29.59	-121.02	-43.09	-141.11	--
Net Profit Growth (%)	17.44	-30.40	-136.29	-49.17	-117.42	--
EPS Growth (%)	24.39	-0.27	-1.19	0.90	-19.29	--
Book Value Growth (%)	-14.38	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	0.02	0.13	0.08	0.13	0.54	58.20
Short term debt to equity ratio	0.05	0.09	0.05	0.06	--	--
Current Ratio	7.73	6.78	12.15	8.73	18.74	17.20
Quick Ratio	7.73	6.90	12.10	9.07	18.22	16.16
Interest Coverage	-76.15	-89.17	-91.56	-97.33	--	--

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	--	11,117.49	--	--	--
Asset Turnover	--	--	0.00	--	--	--
Receivable days	--	--	35,752.09	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.